MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Effect of opicapone and entacapone on early morning-OFF pattern in Parkinson’s disease patients with motor fluctuations

    A. Videnovic, W. Poewe, A. Lees, J. Ferreira, O. Klepitskaya, R. Loureiro, D. Magalhães, J.F Rocha, P. Soares-da-Silva (Boston, MA, USA)

    Objective: To evaluate the effect of opicapone (OPC) 50 mg versus entacapone (ENT) on early morning-OFF (EMO) pattern. Background: OPC, a once-daily catechol-O-methyltransferase inhibitor, was…
  • MDS Virtual Congress 2020

    A monocentric experience of Apomorphine pump follow-up on PD patients: The Optipump Cohort

    C. Virbel-Fleischman, M. Houot, Y. Rétory, S. Hardy, J.C Corvol, D. Grabli (Gentilly, France)

    Objective: The goal of this study is to describe the factors that may have an impact on Continuous Subcutaneous Apomorphine Infusion (CSAI) therapy initiation and…
  • MDS Virtual Congress 2020

    Distribution of intranasal hNSCs in a mouse model of MPTP-induced Parkinson’s disease

    F. Wang, Y.T Zhang, S.Z Wei, C. Ren, C.F Liu (Suzhou, China)

    Objective: We aimed to map the distribution of human neural stem cells (hNSCs) in the brain and peripheral tissues after intranasal administration in a mouse…
  • MDS Virtual Congress 2020

    Evaluation of Advanced Parkinson’s Patients Using Levodopa Carbidopa Instestinal Gel: Results of the Aegean Region of Turkey

    O. Yilmaz Kusbeci, A. Acarer, B. Donmez Colakoglu, I. Inci, R. Cakmur, A. Akyol, Z. Colakoglu (Izmir, Turkey)

    Objective: The aim of the present study was to evaluate the outcome of LCIG treatment in advanced PD in Aegean Region of Turkey. Background: Levodopa/carbidopa…
  • MDS Virtual Congress 2020

    Secondary Vascular Parkinsonism: Role of increasing levels cortisol in the cognitive impairment

    D. Akramova (Tashkent, Uzbekistan)

    Objective: Elevated cortisol levels are found in many diseases, including infectious, related to aging, depression, and associated with a depressive status. Elevated cortisol levels are…
  • MDS Virtual Congress 2020

    Automated classification of neurodegenerative parkinsonian syndromes using multimodal magnetic resonance imaging in a clinical setting

    L. Chougar, J. Faouzi, N. Pyatigorskaya, O. Colliot, S. Lehéricy (Paris, France)

    Objective: To evaluate the accuracy for the categorization of parkinsonian syndromes of a machine learning algorithm trained with a research cohort and tested on an…
  • MDS Virtual Congress 2020

    Cardiac Autonomic Dysfunction in Patients with Multiple System Atrophy: A cross-sectional study

    G. Ganagarajan, T.N Sathyaprabha, K. Udupa, M.R Raghurama, K. Kuravatti, B.S Prasad, R. Yadav, K. Kambhampati, P. John (Bangalore, India)

    Objective: The study aimed to assess cardiac autonomic dysfunction in patients with multiple system atrophy (MSA). Background: MSA is a progressive neurodegenerative disorder with predominant…
  • MDS Virtual Congress 2020

    Topographical subtypes of multiple system atrophy: MRI and PET studies

    C. Lee, K. Park, N. Choi, S. Kim, J. Ko, D. Doudet (Seoul, Republic of Korea)

    Objective: To investigate the MSA subtypes based on the topography of MSA lesions, employing MRI, PET with [18F]FP-CIT and [18F]FDG PET. Background: Based on the…
  • MDS Virtual Congress 2020

    Sleep-related Symptoms in Multiple System Atrophy: Determinants and Impact on disease severity

    J.Y Lin, L.Y Zhang, B. Cao, QQ. Wei, H.F Shang (Chengdu, China)

    Objective: To investigate the prevalence and determinants of sleep-related symptoms in multiple system atrophy (MSA) and the impact of sleep disturbances on disease severity. Background:…
  • MDS Virtual Congress 2020

    Brain 5-HT1 receptor binding in multiple system atrophy: A [18F]-MPPF PET study

    M. Meyer, I. Sibon, F. Lamarre, J. Asselineau, A. Foubert-Samier, J. Mazère, A. Delamarre, O. Rascol, A. Pavy-Le Traon, F. Tison, P. Fernandez, W. Meissner (Bordeaux, France)

    Objective: The primary objective was to compare brain 5-HT1a receptor binding between patients with multiple system atrophy (MSA) and healthy controls (HC). The secondary objectives…
  • « Previous Page
  • 1
  • …
  • 654
  • 655
  • 656
  • 657
  • 658
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Carpal Tunnel Syndrome in Patients with Tremor
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley